Omalizumab (anti-IgE)

Catalog No.A2044 Synonyms: Olizumab, rhuMab-E25

For research use only.
Not for use in humans.

Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research.

Omalizumab (anti-IgE)

Purity & Quality Control

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research.

Protocol (from reference)

Product Details

CAS No. 242138-07-4
Formulation PBS Buffer, PH 7.4
Isotype Human IgG1
Application Omalizumab (anti-IgE)
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Sterility 0.2 μM filtered

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Omalizumab (anti-IgE) | Omalizumab (anti-IgE) supplier | purchase Omalizumab (anti-IgE) | Omalizumab (anti-IgE) cost | Omalizumab (anti-IgE) manufacturer | order Omalizumab (anti-IgE) | Omalizumab (anti-IgE) distributor